Outcome Assessment of Patients With Metastatic Renal Cell Carcinoma Under Systemic Therapy Using Artificial Neural Networks
Author:
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference31 articles.
1. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease;Janzen;Urol Clin North Am,2003
2. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2004
3. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial;Motzer;Lancet,2008
4. Metastatic renal cell carcinoma: recent advances in the targeted therapy era;Di Lorenzo;Eur Urol,2009
5. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2009
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Application of artificial intelligence in the diagnosis and treatment of urinary tumors;Frontiers in Oncology;2024-08-12
2. The Integration of Artificial Intelligence into Clinical Practice;Applied Biosciences;2024-01-01
3. Artificial Intelligence in Urooncology: What We Have and What We Expect;Cancers;2023-08-26
4. Artificial intelligence for renal cancer: From imaging to histology and beyond;Asian Journal of Urology;2022-07
5. Differentiating Benign from Malignant Renal Tumors Using T2 ‐ and Diffusion‐Weighted Images: A Comparison of Deep Learning and Radiomics Models Versus Assessment from Radiologists;Journal of Magnetic Resonance Imaging;2021-08-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3